Cipla

CIPLA · NSE · INR

1344,00 ₹Variazione rispetto alla chiusura precedente: −0,15%Variazione assoluta: −2,00 ₹

Chiusura · 1 ottobre 2026

Profilo dell'azienda

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Descrizione disponibile in inglese.

Dati societari

Settore
Salute
Industria
Drug Manufacturers - Specialty & Generic
Paese
India
Sede
Cipla House, 400013, Mumbai
Dipendenti
31.369
Quotazione
CIPLA · NSE
Valuta
INR
ISIN
INE059A01026
Sito web
cipla.com